News from WCM

Pulmonologist Dr. Fernando Martinez hopes that a simple questionnaire can help identify patients with COPD who are undiagnosed—and improve countless lives around the globe.

A short checklist of signs and symptoms could be a critical tool for directing limited medical resources to the most urgent cases of anthrax following a mass exposure to the deadly bacterium.

This year's match, announced on March 15, was the largest on record.

Gerontologist Dr. Sara Czaja studies how technology can help older adults live happier, healthier, more active lives.

Dr. Carl Nathan, chairman of the Department of Microbiology and Immunology at Weill Cornell Medicine, has been awarded the institution’s Joan and Sanford I. Weill Exemplary Achievement Award.

On Feb. 25, 42 students in the Class of 2021 earned their short white coats during the annual white coat ceremony, launching the next phase of their medical careers.

Biochemist Dr. Lewis Cantley is finding increasing evidence of a strong connection between sugar and cancer.

Despite comprising up to 80 percent of global health faculty members and workers, women hold only a fraction of global health leadership roles.

On the heels of the civil rights movement, a small, Ivy League medical school in New York City, long committed to advancing diversity in medicine and science, launched a summer fellowship program designed to do just that.

Most of the reasons why American patients receive care from multiple providers are related to numerous modifiable causes such as patient preferences, physician referrals and health system factors —not medical need—according to a qualitative study by Weill Cornell Medicine researchers.  

The third annual NYC Health Hackathonbrought together nearly 200 students and faculty members from Weill Cornell Medicine, Cornell’s Ithaca campus, and several local and national academic institutions, to develop high-tech healthcare innovations. 

Researchers have long known that dysfunction in the body’s innate immune system breaks the first line of defense against invading pathogens, enabling diseases to flourish unchecked.

Chelsea Clinton is a public health advocate, researcher and educator. But being a mother has deepened her passion for children’s health, she explained in a talk on Feb. 5 at Weill Cornell Medicine.

Diffuse Intrinsic Pontine Glioma (DIPG) is every parent’s worst nightmare: a rare and incurable type of brain cancer that affects young children. Dr. Mark Souweidane decided to make curing this cancer his “Holy Grail”—and his progress since then has been impressive.

An investigation by Weill Cornell Medicine scientists has yielded two breakthroughs in the pursuit of combating growing resistance to tuberculosis treatments. 

Treating patients with advanced, metastatic esophageal cancer with an immune-system boosting drug called pembrolizumab, known by its brand name Keytruda, led to regression of tumors in some patients, according to results of a phase 2 clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

A recent alumna runs the World Marathon Challenge

New studies from Weill Cornell Medicine researchers have revealed the importance of two gene-regulation proteins in the development of common immune cell cancers called lymphomas.

Dr. Lisa Newman and her multidisciplinary research team study why breast cancer outcomes vary by patients’ race and ethnicity.

How a soap opera inspired this leading breast cancer surgeon and researcher.